T1	Drug_or_compound 0 7	AVE8062
T2	Multi-tissue_structure 41 49	vascular
T8	Pathological_formation 132 137	tumor
T10	Multi-tissue_structure 192 214	tumor vascular network
T13	Cell 308 325	endothelial cells
T14	Cellular_component 330 350	extracellular matrix
T17	Pathological_formation 421 426	tumor
T19	Drug_or_compound 443 468	vascular-targeting agents
T21	Drug_or_compound 470 473	VTA
T22	Drug_or_compound 476 480	VTAs
T23	Drug_or_compound 513 534	antiangiogenic agents
T25	Drug_or_compound 539 565	vascular-disrupting agents
T28	Drug_or_compound 567 571	VDAs
T29	Drug_or_compound 574 578	VTAs
T33	Pathological_formation 692 704	tumor masses
T34	Tissue 716 731	tumor periphery
T37	Gene_or_gene_product 836 849	VEGF receptor
T39	Drug_or_compound 851 855	VDAs
T41	Multi-tissue_structure 905 918	tumor vessels
T43	Pathological_formation 958 964	masses
T45	Pathological_formation 1022 1044	peripheral tumor layer
T46	Drug_or_compound 1046 1050	VDAs
T48	Drug_or_compound 1158 1177	small-molecule VDAs
T49	Drug_or_compound 1183 1193	flavonoids
T50	Drug_or_compound 1203 1239	5,6-dimethylxanthenone-4-acetic acid
T51	Drug_or_compound 1241 1246	DMXAA
T52	Drug_or_compound 1253 1285	microtubule-destabilizing agents
T53	Drug_or_compound 1421 1439	antitubulin agents
T54	Drug_or_compound 1445 1483	combretastatin A4-phosphate derivative
T55	Drug_or_compound 1485 1493	AVE8062A
T4	Drug_or_compound 15 29	combretastatin
